Caplin Point Laboratories Limited

NSE: CAPLIPOINT

26

total announcements

CAPLIPOINT.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 16 Oct 2026

Market Cap

₹17,496 Cr

P/E (TTM)

26.4

P/E (Forward)

20.8

EPS (TTM)

₹87.28

52W Low

₹1,500.30

52W High

₹2,990.00

Dividend Yield

0.34%

Beta

0.42

Price / Book

5.0

Debt / Equity

0.1

Revenue (TTM)

₹2,287 Cr

Gross Margin

59.97%

Operating Margin

31.43%

NSERecord DateDividend12 Aug 2026

Caplin Point Laboratories Limited

Record Date

Caplin Point Laboratories Limited has announced the record date for the purpose of dividend as September 18, 2026, in accordance with Regulation 42 of the SEBI Listing Regulations. The company's 35th Annual General Meeting will be held on September 25, 2026.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults12 Aug 2026

Caplin Point Laboratories Limited

Outcome of Board Meeting

Caplin Point Laboratories Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a net profit of Rs. 120.38 crores. The company has also recommended a final dividend of Rs. 4 per equity share and approved the re-appointment of Dr. Sridhar Ganesan as Managing Director and the appointment of Mr. D. Muralidharan as Whole-Time Director.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults30 Jul 2026

Caplin Point Laboratories Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Caplin Point Laboratories Limited has informed the Exchange about a post-results conference call with analysts and investors to discuss the financial performance for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSECertificate under SEBI (Depositories and Participants) Regulations, 201811 Jul 2026

Caplin Point Laboratories Limited

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Caplin Point Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, received from Integrated Registry Management Services Private Limited, the Registrar and Transfer Agent of the Company, for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSETrading Window27 Jun 2026

Caplin Point Laboratories Limited

Trading Window

Caplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the finalization of unaudited Financial Results for the quarter ending June 30, 2026.

Read more →📎 1 attachment
NSECopy of Newspaper Publication22 Jun 2026

Caplin Point Laboratories Limited

Copy of Newspaper Publication

Caplin Point Laboratories Limited has informed the exchanges about the publication of newspaper advertisements regarding the transfer of unclaimed dividends and equity shares to the Investor Education and Protection Fund (IEPF). This action is taken in accordance with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, and is a routine regulatory compliance disclosure.

Read more →📎 1 attachment
← PreviousPage 2 of 2